TrialResults-center.org

Menu

Troglitazone antidiabetic drugs

Diabetes type 2

All type of patients : 2 trials - TRIPOD (Buchanan) - US DDP troglitazone (Knowler)

troglitazone vs placebo

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
normoglycemia	no data
cardiovascular events	no data
Cardiovascular death	no data
myocardial infarction (fatal and non fatal)	no data
stroke (fatal and non fatal)	no data
cardiovascular death, MI, stroke	no data
Diabetes	no data
hospitalisation for heart failure	no data
All cause death	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

See more clinical conditions

People with impaired glucose tolerance: 2 trials - TRIPOD (Buchanan) - US DDP troglitazone (Knowler)

troglitazone vs placebo

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
normoglycemia	no data
cardiovascular events	no data
Cardiovascular death	no data
myocardial infarction (fatal and non fatal)	no data
stroke (fatal and non fatal)	no data
cardiovascular death, MI, stroke	no data
Diabetes	no data
hospitalisation for heart failure	no data
All cause death	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -